Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Dermatitis, Atopic

3,4-methylenedioxyamphetamine has been researched along with Dermatitis, Atopic in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research Excerpts

ExcerptRelevanceReference
"Twenty-four patients with mild atopic eczema and 24 patients with mild allergic rhinitis kissed with lovers or spouses freely for 30 min while listening to soft music."1.33Kissing selectively decreases allergen-specific IgE production in atopic patients. ( Kimata, H, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimata, H2

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Dermatitis, Atopic

ArticleYear
Kissing reduces allergic skin wheal responses and plasma neurotrophin levels.
    Physiology & behavior, 2003, Volume: 80, Issue:2-3

    Topics: Adult; Allergens; Case-Control Studies; Dermatitis, Atopic; Female; Histamine; Humans; Lip; Love; Ma

2003
Kissing selectively decreases allergen-specific IgE production in atopic patients.
    Journal of psychosomatic research, 2006, Volume: 60, Issue:5

    Topics: Adult; Antibody Formation; Choice Behavior; Cytokines; Dermatitis, Atopic; Female; Humans; Immunoglo

2006